{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T21:27:55Z","timestamp":1782941275038,"version":"3.54.5"},"reference-count":67,"publisher":"American Association for Cancer Research (AACR)","issue":"5","license":[{"start":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T00:00:00Z","timestamp":1747958400000},"content-version":"vor","delay-in-days":22,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>Lung-sparing radical pleurectomy with intraoperative photodynamic therapy (PDT) demonstrates remarkable survival for patients with pleural mesothelioma. Nevertheless, most patients treated with this multimodal approach will develop local tumor recurrence. An understanding of potential causes of treatment failure is central to developing mitigation strategies. Surgery importantly reduces disease burden but also produces tumor-promoting inflammation, as demonstrated through transcriptomic analysis of pleural mesothelioma specimens. Using preclinical models in the setting of combination therapy, we separated the benefit of surgical resection from its counterproductive effects on therapeutic outcome. Specifically, we evaluated mechanisms by which surgically induced inflammation can be therapy-limiting in a murine model of tumor incision (TI) introduced by a surgical cut across the tumor. In this TI model, we identified distinct TI-altered patterns in innate and adaptive inflammatory cells in murine mesothelioma tumors, and we studied changes in these patterns with the addition of PDT. TI introduction of an immunosuppressive environment is established via upregulation of PD-1\/PD-L1 expression on tumor cells, T cells, and myeloid cells that is partially resolved by PDT. Immune dysfunction is further mitigated by the addition of PD-1 blockade, leading to curative potential in a process that requires Ly6G+ neutrophils and CD8+ T cells. Overall, these studies suggest that, without PDT, surgical modulation of immune cell trafficking and functionality leads to systemic immunosuppression. This immunosuppressive state potentially interferes with the generation of antitumor immunity by PDT. However, targeted inhibition of surgery-induced signaling in the PD-l\/PD-L1 pathway counteracts surgery\u2019s immunosuppressive outcomes to enhance PDT efficacy in the intraoperative setting.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>Surgery combined with PDT extends survival for patients with mesothelioma, but these patients are still at risk for tumor recurrence, in part due to the immunosuppressive effects of surgery. We find, in a mouse model, that combining surgery, PDT, and immune checkpoint blockade maximizes the efficacy of these therapies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/2767-9764.crc-24-0571","type":"journal-article","created":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T07:38:57Z","timestamp":1746603537000},"page":"841-856","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["PD-1 Blockade Mitigates Surgery-Induced Immunosuppression and Increases the Efficacy of Photodynamic Therapy for Pleural Mesothelioma"],"prefix":"10.1158","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1141-3391","authenticated-orcid":false,"given":"Gwendolyn M.","family":"Cramer","sequence":"first","affiliation":[{"name":"1Department of Radiation Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2193-493X","authenticated-orcid":false,"suffix":"IV","given":"Richard W.","family":"Davis","sequence":"additional","affiliation":[{"name":"1Department of Radiation Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-2794-3361","authenticated-orcid":false,"given":"Emmanouil","family":"Papasavvas","sequence":"additional","affiliation":[{"name":"2The Wistar Institute, Philadelphia, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0572-502X","authenticated-orcid":false,"given":"Astero","family":"Klampatsa","sequence":"additional","affiliation":[{"name":"3Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2987-592X","authenticated-orcid":false,"given":"Joann M.","family":"Miller","sequence":"additional","affiliation":[{"name":"1Department of Radiation Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1595-271X","authenticated-orcid":false,"given":"Shirron","family":"Carter","sequence":"additional","affiliation":[{"name":"1Department of Radiation Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-7579-1611","authenticated-orcid":false,"given":"Ruth","family":"Ikpe","sequence":"additional","affiliation":[{"name":"1Department of Radiation Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-3305-4294","authenticated-orcid":false,"given":"Min","family":"Yuan","sequence":"additional","affiliation":[{"name":"1Department of Radiation Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7424-9356","authenticated-orcid":false,"given":"Sandy","family":"Widura","sequence":"additional","affiliation":[{"name":"2The Wistar Institute, Philadelphia, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-9046-8799","authenticated-orcid":false,"given":"R. Sonali","family":"Majumdar","sequence":"additional","affiliation":[{"name":"2The Wistar Institute, Philadelphia, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-2347-4548","authenticated-orcid":false,"given":"Sally","family":"McNulty","sequence":"additional","affiliation":[{"name":"1Department of Radiation Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7954-1288","authenticated-orcid":false,"given":"Mary","family":"Putt","sequence":"additional","affiliation":[{"name":"4Department of Biostatistics, University of Pennsylvania, Philadelphia, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1536-0418","authenticated-orcid":false,"given":"Andrew V.","family":"Kossenkov","sequence":"additional","affiliation":[{"name":"2The Wistar Institute, Philadelphia, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5799-6759","authenticated-orcid":false,"given":"Luis J.","family":"Montaner","sequence":"additional","affiliation":[{"name":"2The Wistar Institute, Philadelphia, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2413-7082","authenticated-orcid":false,"given":"Sunil","family":"Singhal","sequence":"additional","affiliation":[{"name":"5Division of Thoracic Surgery, Department of Surgery, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-7597-8070","authenticated-orcid":false,"given":"Edmund K.","family":"Moon","sequence":"additional","affiliation":[{"name":"3Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6598-3752","authenticated-orcid":false,"given":"Steven M.","family":"Albelda","sequence":"additional","affiliation":[{"name":"3Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6960-5882","authenticated-orcid":false,"given":"Keith A.","family":"Cengel","sequence":"additional","affiliation":[{"name":"1Department of Radiation Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5499-8377","authenticated-orcid":false,"given":"Theresa M.","family":"Busch","sequence":"additional","affiliation":[{"name":"1Department of Radiation Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2025,5,23]]},"reference":[{"key":"2025052303231586200_bib1","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1158\/1940-6207.CAPR-15-0347","article-title":"Inflammation-related IL1\u03b2\/IL1R signaling promotes the development of asbestos-induced malignant mesothelioma","volume":"9","author":"Kadariya","year":"2016","journal-title":"Cancer Prev Res (Phila)"},{"key":"2025052303231586200_bib2","doi-asserted-by":"crossref","first-page":"12611","DOI":"10.1073\/pnas.1006542107","article-title":"Programmed necrosis induced by asbestos in human mesothelial cells causes high-mobility group box 1 protein release and resultant inflammation","volume":"107","author":"Yang","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2025052303231586200_bib3","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/BF01534421","article-title":"Patho- and immunobiology of malignant mesothelioma: characterisation of tumour infiltrating leucocytes and cytokine production in a murine model","volume":"39","author":"Bielefeldt-Ohmann","year":"1994","journal-title":"Cancer Immunol Immunother"},{"key":"2025052303231586200_bib4","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/174_2022_333","article-title":"Advances in radiation therapy for malignant pleural mesothelioma","volume-title":"Advances in radiation oncology in lung cancer","author":"Cramer","year":"2023"},{"key":"2025052303231586200_bib5","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.athoracsur.2018.06.015","article-title":"A clinical trial of TumorGlow to identify residual disease during pleurectomy and decortication","volume":"107","author":"Predina","year":"2019","journal-title":"Ann Thorac Surg"},{"key":"2025052303231586200_bib6","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1016\/j.jtho.2018.04.032","article-title":"A phase I trial of surgical resection and intraoperative hyperthermic cisplatin and gemcitabine for pleural mesothelioma","volume":"13","author":"Burt","year":"2018","journal-title":"J Thorac Oncol"},{"key":"2025052303231586200_bib7","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/s41571-022-00649-7","article-title":"Immunotherapy approaches for malignant pleural mesothelioma","volume":"19","author":"Fennell","year":"2022","journal-title":"Nat Rev Clin Oncol"},{"key":"2025052303231586200_bib8","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s40425-018-0398-7","article-title":"Combining surgery and immunotherapy: turning an immunosuppressive effect into a therapeutic opportunity","volume":"6","author":"Bakos","year":"2018","journal-title":"J Immunother Cancer"},{"key":"2025052303231586200_bib9","doi-asserted-by":"crossref","first-page":"4030","DOI":"10.1245\/s10434-020-09371-z","article-title":"Targeting myeloid-derived suppressor cells for premetastatic niche disruption after tumor resection","volume":"28","author":"Tang","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"2025052303231586200_bib10","doi-asserted-by":"crossref","first-page":"e15497","DOI":"10.14814\/phy2.15497","article-title":"Surgical wounding enhances pro-tumor macrophage responses and accelerates tumor growth and lung metastasis in a triple negative breast cancer mouse model","volume":"10","author":"McDonald","year":"2022","journal-title":"Physiol Rep"},{"key":"2025052303231586200_bib11","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.3390\/ijms18081787","article-title":"Dysfunctional natural killer cells in the aftermath of cancer surgery","volume":"18","author":"Angka","year":"2017","journal-title":"Int J Mol Sci"},{"key":"2025052303231586200_bib12","doi-asserted-by":"crossref","first-page":"e0155947","DOI":"10.1371\/journal.pone.0155947","article-title":"Surgical stress abrogates pre-existing protective T cell mediated anti-tumor immunity leading to postoperative cancer recurrence","volume":"11","author":"Ananth","year":"2016","journal-title":"PLoS One"},{"key":"2025052303231586200_bib13","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1007\/s00262-015-1740-2","article-title":"Surgical trauma induces postoperative T-cell dysfunction in lung cancer patients through the programmed death-1 pathway","volume":"64","author":"Xu","year":"2015","journal-title":"Cancer Immunol Immunother"},{"key":"2025052303231586200_bib14","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.athoracsur.2016.08.071","article-title":"Extended pleurectomy-decortication-based treatment for advanced stage epithelial mesothelioma yielding a median survival of nearly three years","volume":"103","author":"Friedberg","year":"2017","journal-title":"Ann Thorac Surg"},{"key":"2025052303231586200_bib15","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/php.13253","article-title":"Photodynamic therapy and immunity: an update","volume":"96","author":"Falk-Mahapatra","year":"2020","journal-title":"Photochem Photobiol"},{"key":"2025052303231586200_bib16","first-page":"2908","article-title":"Evidence for an important role of neutrophils in the efficacy of photodynamic therapy in vivo","volume":"56","author":"de Vree","year":"1996","journal-title":"Cancer Res"},{"key":"2025052303231586200_bib17","doi-asserted-by":"crossref","first-page":"4348","DOI":"10.4049\/jimmunol.1103621","article-title":"IL-17 promotes neutrophil entry into tumor-draining lymph nodes following induction of sterile inflammation","volume":"191","author":"Brackett","year":"2013","journal-title":"J Immunol"},{"key":"2025052303231586200_bib18","doi-asserted-by":"crossref","first-page":"10501","DOI":"10.1158\/0008-5472.CAN-07-1778","article-title":"Photodynamic therapy enhancement of antitumor immunity is regulated by neutrophils","volume":"67","author":"Kousis","year":"2007","journal-title":"Cancer Res"},{"key":"2025052303231586200_bib19","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/lsm.22934","article-title":"A preclinical model to investigate the role of surgically-induced inflammation in tumor responses to intraoperative photodynamic therapy","volume":"50","author":"Davis","year":"2018","journal-title":"Lasers Surg Med"},{"key":"2025052303231586200_bib20","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1158\/2767-9764.CRC-22-0494","article-title":"Surgical inflammation alters immune response to intraoperative photodynamic therapy","volume":"3","author":"Davis","year":"2023","journal-title":"Cancer Res Commun"},{"key":"2025052303231586200_bib21","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1084\/jem.20131916","article-title":"PD-L1 is a novel direct target of HIF-1\u03b1, and its blockade under hypoxia enhanced MDSC-mediated T cell activation","volume":"211","author":"Noman","year":"2014","journal-title":"J Exp Med"},{"key":"2025052303231586200_bib22","doi-asserted-by":"crossref","first-page":"5514","DOI":"10.1158\/1078-0432.CCR-16-1673","article-title":"Fractionated radiation therapy stimulates antitumor immunity mediated by both resident and infiltrating polyclonal T-cell populations when combined with PD-1 blockade","volume":"23","author":"Dovedi","year":"2017","journal-title":"Clin Cancer Res"},{"key":"2025052303231586200_bib23","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1111\/php.13300","article-title":"Photodynamic therapy and immune checkpoint blockade\u2020","volume":"96","author":"Cramer","year":"2020","journal-title":"Photochem Photobiol"},{"key":"2025052303231586200_bib24","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"2025052303231586200_bib25","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1186\/1471-2105-12-323","article-title":"RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome","volume":"12","author":"Li","year":"2011","journal-title":"BMC Bioinformatics"},{"key":"2025052303231586200_bib26","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"key":"2025052303231586200_bib27","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/s41587-019-0114-2","article-title":"Determining cell type abundance and expression from bulk tissues with digital cytometry","volume":"37","author":"Newman","year":"2019","journal-title":"Nat Biotechnol"},{"key":"2025052303231586200_bib28","doi-asserted-by":"crossref","first-page":"D1005","DOI":"10.1093\/nar\/gkq1184","article-title":"NCBI GEO: archive for functional genomics data sets\u201310 years on","volume":"39","author":"Barrett","year":"2011","journal-title":"Nucleic Acids Res"},{"key":"2025052303231586200_bib29","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1002\/ijc.2910520609","article-title":"Establishment of a murine model of malignant mesothelioma","volume":"52","author":"Davis","year":"1992","journal-title":"Int J Cancer"},{"key":"2025052303231586200_bib30","doi-asserted-by":"crossref","first-page":"22850","DOI":"10.1038\/srep22850","article-title":"Human malignant mesothelioma is recapitulated in immunocompetent BALB\/c mice injected with murine AB cells","volume":"6","author":"Mezzapelle","year":"2016","journal-title":"Sci Rep"},{"key":"2025052303231586200_bib31","doi-asserted-by":"crossref","first-page":"5051","DOI":"10.4049\/jimmunol.171.10.5051","article-title":"IL-2 intratumoral immunotherapy enhances CD8+ T cells that mediate destruction of tumor cells and tumor-associated vasculature: a novel mechanism for IL-2","volume":"171","author":"Jackaman","year":"2003","journal-title":"J Immunol"},{"key":"2025052303231586200_bib32","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.omto.2020.07.005","article-title":"Analysis and augmentation of the immunologic bystander effects of CAR T cell therapy in a syngeneic mouse cancer model","volume":"18","author":"Klampatsa","year":"2020","journal-title":"Mol Ther Oncolytics"},{"key":"2025052303231586200_bib33","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/carcin\/bgt322","article-title":"Long-term exposure of mesothelial cells to SV40 and asbestos leads to malignant transformation and chemotherapy resistance","volume":"35","author":"Cleaver","year":"2014","journal-title":"Carcinogenesis"},{"key":"2025052303231586200_bib34","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1189\/jlb.5TA0814-373","article-title":"An optimized disaggregation method for human lung tumors that preserves the phenotype and function of the immune cells","volume":"97","author":"Quatromoni","year":"2015","journal-title":"J Leukoc Biol"},{"key":"2025052303231586200_bib35","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1002\/eji.202048960","article-title":"PD-1-specific \u201cBlocking\u201d antibodies that deplete PD-1+ T cells present an inconvenient variable in preclinical immunotherapy experiments","volume":"51","author":"Polesso","year":"2021","journal-title":"Eur J Immunol"},{"key":"2025052303231586200_bib36","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1021\/acs.jproteome.6b00795","article-title":"Role of TGF beta and PPAR alpha signaling pathways in radiation response of locally exposed heart: integrated global transcriptomics and proteomics analysis","volume":"16","author":"Subramanian","year":"2017","journal-title":"J Proteome Res"},{"key":"2025052303231586200_bib37","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1365-2567.2010.03382.x","article-title":"PD-1 negatively regulates interleukin-12 expression by limiting STAT-1 phosphorylation in monocytes\/macrophages during chronic hepatitis C virus infection","volume":"132","author":"Ma","year":"2011","journal-title":"Immunology"},{"key":"2025052303231586200_bib38","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nri.2017.108","article-title":"The diverse functions of the PD1 inhibitory pathway","volume":"18","author":"Sharpe","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"2025052303231586200_bib39","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/COC.0000000000000239","article-title":"CTLA-4 and PD-1 pathways: similarities, differences, and implications of their inhibition","volume":"39","author":"Buchbinder","year":"2016","journal-title":"Am J Clin Oncol"},{"key":"2025052303231586200_bib40","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1562\/0031-8655(2001)074<0712:IOSNRI>2.0.CO;2","article-title":"Induction of systemic neutrophil response in mice by photodynamic therapy of solid tumors","volume":"74","author":"Cecic","year":"2001","journal-title":"Photochem Photobiol"},{"key":"2025052303231586200_bib41","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s00441-017-2774-x","article-title":"A head-to-tail view of L-selectin and its impact on neutrophil behaviour","volume":"371","author":"Ivetic","year":"2018","journal-title":"Cell Tissue Res"},{"key":"2025052303231586200_bib42","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/php.13040","article-title":"Luminol chemiluminescence reports photodynamic therapy-generated neutrophil activity in vivo and serves as a biomarker of therapeutic efficacy","volume":"95","author":"Davis","year":"2019","journal-title":"Photochem Photobiol"},{"key":"2025052303231586200_bib43","first-page":"3904","article-title":"Altered expression of interleukin 6 and interleukin 10 as a result of photodynamic therapy in vivo","volume":"57","author":"Gollnick","year":"1997","journal-title":"Cancer Res"},{"key":"2025052303231586200_bib44","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s13577-015-0118-2","article-title":"Photodynamic therapy mediates innate immune responses via fibroblast-macrophage interactions","volume":"28","author":"Zulaziz","year":"2015","journal-title":"Hum Cell"},{"key":"2025052303231586200_bib45","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/s41419-019-2149-1","article-title":"Cancer-educated mesenchymal stem cells promote the survival of cancer cells at primary and distant metastatic sites via the expansion of bone marrow-derived-PMN-MDSCs","volume":"10","author":"Sai","year":"2019","journal-title":"Cell Death Dis"},{"key":"2025052303231586200_bib46","doi-asserted-by":"crossref","first-page":"e130850","DOI":"10.1172\/jci.insight.130850","article-title":"Neutrophil content predicts lymphocyte depletion and anti-PD1 treatment failure in NSCLC","volume":"4","author":"Kargl","year":"2019","journal-title":"JCI Insight"},{"key":"2025052303231586200_bib47","doi-asserted-by":"crossref","first-page":"3414","DOI":"10.1038\/s41467-021-23731-7","article-title":"Suppression of tumor-associated neutrophils by lorlatinib attenuates pancreatic cancer growth and improves treatment with immune checkpoint blockade","volume":"12","author":"Nielsen","year":"2021","journal-title":"Nat Commun"},{"key":"2025052303231586200_bib48","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.ejcts.2007.01.027","article-title":"Interleukin 6 and interleukin 1 receptor antagonist as early markers of complications after lung cancer surgery","volume":"31","author":"Szczesny","year":"2007","journal-title":"Eur J Cardiothorac Surg"},{"key":"2025052303231586200_bib49","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00384-016-2697-0","article-title":"Comparison of inflammatory responses following robotic and open colorectal surgery: a prospective study","volume":"32","author":"Zawadzki","year":"2017","journal-title":"Int J Colorectal Dis"},{"key":"2025052303231586200_bib50","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1476-9255-8-32","article-title":"Cytokine & chemokine response in the lungs, pleural fluid and serum in thoracic surgery using one-lung ventilation","volume":"8","author":"Breunig","year":"2011","journal-title":"J Inflamm (Lond)"},{"key":"2025052303231586200_bib51","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/eji.201040979","article-title":"PD-L1 expression on tolerogenic APCs is controlled by STAT-3","volume":"41","author":"W\u00f6lfle","year":"2011","journal-title":"Eur J Immunol"},{"key":"2025052303231586200_bib52","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nrclinonc.2018.8","article-title":"Targeting the IL-6\/JAK\/STAT3 signalling axis in cancer","volume":"15","author":"Johnson","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"key":"2025052303231586200_bib53","doi-asserted-by":"crossref","first-page":"104254","DOI":"10.1016\/j.cellimm.2020.104254","article-title":"IL-6 as a major regulator of MDSC activity and possible target for cancer immunotherapy","volume":"359","author":"Weber","year":"2021","journal-title":"Cell Immunol"},{"key":"2025052303231586200_bib54","doi-asserted-by":"crossref","first-page":"11553","DOI":"10.1007\/s13277-016-5098-7","article-title":"Role of interleukin-6 in cancer progression and therapeutic resistance","volume":"37","author":"Kumari","year":"2016","journal-title":"Tumour Biol"},{"key":"2025052303231586200_bib55","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s12094-020-02392-w","article-title":"High expression level of interleukin-1\u03b2 is correlated with poor prognosis and PD-1 expression in patients with lung adenocarcinoma","volume":"23","author":"Ding","year":"2021","journal-title":"Clin Transl Oncol"},{"key":"2025052303231586200_bib56","doi-asserted-by":"crossref","first-page":"11547","DOI":"10.3390\/ijms241411547","article-title":"Comprehensive review: unveiling the pro-oncogenic roles of IL-1\u00df and PD-1\/PD-L1 in NSCLC development and targeting their pathways for clinical management","volume":"24","author":"Castillo","year":"2023","journal-title":"Int J Mol Sci"},{"key":"2025052303231586200_bib57","doi-asserted-by":"crossref","first-page":"e000285","DOI":"10.1136\/jitc-2019-000285","article-title":"IL-6 promotes PD-L1 expression in monocytes and macrophages by decreasing protein tyrosine phosphatase receptor type O expression in human hepatocellular carcinoma","volume":"8","author":"Zhang","year":"2020","journal-title":"J Immunother Cancer"},{"key":"2025052303231586200_bib58","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.3389\/fonc.2020.01360","article-title":"Expression of PD-L1 on monocytes is a novel predictor of prognosis in natural killer\/T-cell lymphoma","volume":"10","author":"Zhang","year":"2020","journal-title":"Front Oncol"},{"key":"2025052303231586200_bib59","doi-asserted-by":"crossref","first-page":"1121557","DOI":"10.3389\/fimmu.2023.1121557","article-title":"Immunotherapy with immune checkpoint inhibitors and predictive biomarkers in malignant mesothelioma: work still in progress","volume":"14","author":"Perrino","year":"2023","journal-title":"Front Immunol"},{"key":"2025052303231586200_bib60","doi-asserted-by":"crossref","first-page":"e241285","DOI":"10.1001\/jamanetworkopen.2024.1285","article-title":"Neoadjuvant-adjuvant vs neoadjuvant-only PD-1 and PD-L1 inhibitors for patients with resectable NSCLC: an indirect meta-analysis","volume":"7","author":"Zhou","year":"2024","journal-title":"JAMA Netw Open"},{"key":"2025052303231586200_bib61","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1097\/01.shk.0000142249.08135.e9","article-title":"Innate immune response in Th1- and Th2-dominant mouse strains","volume":"22","author":"Watanabe","year":"2004","journal-title":"Shock"},{"key":"2025052303231586200_bib62","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1186\/s12885-017-3382-6","article-title":"Whole exome sequencing of an asbestos-induced wild-type murine model of malignant mesothelioma","volume":"17","author":"Sneddon","year":"2017","journal-title":"BMC Cancer"},{"key":"2025052303231586200_bib63","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3390\/cancers8100094","article-title":"Mreg activity in tumor response to photodynamic therapy and photodynamic therapy-generated cancer vaccines","volume":"8","author":"Korbelik","year":"2016","journal-title":"Cancers (Basel)"},{"key":"2025052303231586200_bib64","doi-asserted-by":"crossref","first-page":"6667","DOI":"10.1158\/0008-5472.CAN-17-0740","article-title":"IL10 release upon PD-1 blockade sustains immunosuppression in ovarian cancer","volume":"77","author":"Lamichhane","year":"2017","journal-title":"Cancer Res"},{"key":"2025052303231586200_bib65","doi-asserted-by":"crossref","first-page":"4415","DOI":"10.3390\/cancers14184415","article-title":"Malignant pleural mesothelioma: current understanding of the immune microenvironment and treatments of a rare disease","volume":"14","author":"Tedesco","year":"2022","journal-title":"Cancers (Basel)"},{"key":"2025052303231586200_bib66","doi-asserted-by":"crossref","first-page":"16902","DOI":"10.1038\/s41598-019-52913-z","article-title":"A rationale for surgical debulking to improve anti-PD1 therapy outcome in non small cell lung cancer","volume":"9","author":"Guisier","year":"2019","journal-title":"Sci Rep"},{"key":"2025052303231586200_bib67","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S2213-2600(24)00119-X","article-title":"Extended pleurectomy decortication and chemotherapy versus chemotherapy alone for pleural mesothelioma (MARS 2): a phase 3 randomised controlled trial","volume":"12","author":"Lim","year":"2024","journal-title":"Lancet Respir Med"}],"container-title":["Cancer Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/doi\/10.1158\/2767-9764.CRC-24-0571\/3603418\/crc-24-0571.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/5\/5\/841\/3609256\/crc-24-0571.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/5\/5\/841\/3609256\/crc-24-0571.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T03:23:32Z","timestamp":1747970612000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article\/5\/5\/841\/762601\/PD-1-Blockade-Mitigates-Surgery-Induced"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,1]]},"references-count":67,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5,1]]}},"URL":"https:\/\/doi.org\/10.1158\/2767-9764.crc-24-0571","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/2767-9764.29135020","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29135011","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29135023","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29134981","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29135002","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29135014","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29134990","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29135026","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29135005","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29134996","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29134993","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29135017","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29135029","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29134984","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29134987","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29134999","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29135008","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29134975","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29134978","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/2767-9764.c.7836250","asserted-by":"object"}]},"ISSN":["2767-9764"],"issn-type":[{"value":"2767-9764","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,1]]}}}